Michael Aaron Kelly - 14 Jun 2023 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Director
Signature
/s/ Gabriela Morales-Rivera, attorney-in-fact
Issuer symbol
PRME
Transactions as of
14 Jun 2023
Transactions value $
$0
Form type
4
Filing time
16 Jun 2023, 17:48:28
Previous filing
12 Jun 2023
Next filing
14 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +39.1K $0.00 39.1K 14 Jun 2023 Common Stock 39.1K $14.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.